Breaking News Instant updates and real-time market news.

MDRX

Allscripts

$11.67

-0.25 (-2.10%)

, MCK

McKesson

$155.34

-4.27 (-2.68%)

16:19
08/03/17
08/03
16:19
08/03/17
16:19

Allscripts to acquire McKesson business for $185M in cash

Allscripts (MDRX) announced a definitive agreement to acquire McKesson Corporation's (MCK) hospital and health system IT business, Enterprise Information Solutions, for $185M in cash, subject to adjustment for net debt and working capital. This transaction is targeted to close early in Q4 of calendar 2017, subject to the satisfaction of customary closing conditions, including the expiration or termination of the waiting period under U.S. antitrust laws. Allscripts intends to fund the purchase price through its existing secured credit facilities and cash balances.

MDRX

Allscripts

$11.67

-0.25 (-2.10%)

MCK

McKesson

$155.34

-4.27 (-2.68%)

  • 03

    Aug

  • 21

    Sep

  • 22

    Sep

MDRX Allscripts
$11.67

-0.25 (-2.10%)

05/15/17
BOFA
05/15/17
INITIATION
Target $14
BOFA
Neutral
Allscripts initiated with a Neutral at BofA/Merrill
BofA/Merrill initiated Allscripts with a Neutral and a $14 price target.
05/15/17
05/15/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Jazz Pharmaceuticals (JAZZ) initiated with an Outperform at RBC Capital. 2. Visteon (VC) initiated with a Sector Perform at RBC Capital. 3. Allscripts (MDRX) initiated with a Neutral at BofA/Merrill. 4. Independent Bank (INDB) initiated with a Neutral at Piper Jaffray. 5. Karyopharm (KPTI) initiated with an Overweight at Cantor. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/25/17
JEFF
05/25/17
NO CHANGE
JEFF
After hospital survey, Jefferies says buy Allscripts and Cerner
Jefferies analyst Sean Dodge says his survey of hospital executives indicates the pace of bookings growth for EHR vendors will continue uninterrupted despite the political uncertainty overhanging the space. Concerns of a slowdown are weighing on valuations, Dodge tells investors in a research note. He likes shares of Allscripts (MDRX) and Cerner (CERN) for their "integrated platforms and exposure to the hospital market." The analyst recommends buying both stocks.
06/19/17
LEER
06/19/17
DOWNGRADE
Target $13
LEER
Market Perform
Allscripts downgraded to Market Perform from Outperform at Leerink
Leerink analyst David Larsen downgraded Allscripts (MDRX) to Market Perform and lowered his price target for the shares to $13 from $15. The analyst sees "significant attrition risk" to the company's Sunrise base as his channel checks indicate Cerner (CERN) and Epic are winning the vast majority of share. Further, the Republican healthcare bill "may put even more pressure on hospital budgets," Larsen tells investors in a research note.
MCK McKesson
$155.34

-4.27 (-2.68%)

05/23/17
JPMS
05/23/17
UPGRADE
Target $189
JPMS
Overweight
McKesson upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Lisa Gill upgraded McKesson to Overweight and raised her price target for the shares to $189 from $167. The analyst believes additional value should be unlocked from the Change transaction and that the valuation discount versus peers is unwarranted.
05/23/17
05/23/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. McKesson (MCK) upgraded to Overweight from Neutral at JPMorgan with analyst Lisa Gill saying she believes additional value should be unlocked from the Change transaction and that the valuation discount versus peers is unwarranted. 2. Aegion (AEGN) upgraded to Buy from Hold at Craig-Hallum with analyst Eric Stine saying the recent pullback provides an attractive opportunity to own a "high-quality company" with positive trends across much of its business. 3. Wingstop (WING) upgraded to Conviction Buy from Buy at Goldman Sachs with analyst Karen Holthouse saying there is upside to her $36 price target. Holthouse believes Wingstop is well positioned for digital ordering and off-premise tailwinds and expects an acceleration in same-store-sales driven by national advertising momentum. 4. Parexel (PRXL) upgraded to Neutral from Sell at Goldman Sachs with analyst Robert Jones citing reduced consensus expectations and industry consolidation. 5. On Deck Capital (ONDK) upgraded to Outperform from Market Perform at FBR Capital with analyst Bob Ramsey saying he believes the company's path to profitability creates "significant" upside for the shares over the next 12 months. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/24/17
MSCO
05/24/17
NO CHANGE
Target $179
MSCO
Overweight
McKesson price target raised to $179 on earnings acceleration at Morgan Stanley
Morgan Stanley analyst Ricky Goldwasser raised McKesson's price target to $179 from $164 saying 2018 guidance sets a path for earnings acceleration over the next 18 months supported by improved sourcing, easing comps, and acquisitions. Shares of McKesson are Overweight rated.
06/29/17
LEER
06/29/17
NO CHANGE
Target $170
LEER
Market Perform
McKesson price target raised to $170 from $140 at Leerink
Leerink analyst David Larsen raised his price target for McKesson to $170 following the company's analyst day. The depth of the company's specialty solutions and expansion activities impressed us, but no new long-term operating earnings goals were provided, Larsen tells investors in a research note. The analyst remains skeptical on McKesson's ability to get back to double digit earnings growth in the near-term and keeps a Market Perform rating on the shares.

TODAY'S FREE FLY STORIES

PDCO

Patterson Companies

$34.82

-1.22 (-3.39%)

07:02
11/21/17
11/21
07:02
11/21/17
07:02
Earnings
Patterson Companies reports Q2 adjusted EPS 51c, consensus 54c »

Reports Q2 revenue $1.4B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 28

    Nov

BLRX

BioLineRx

$1.05

0.04 (3.96%)

07:02
11/21/17
11/21
07:02
11/21/17
07:02
Earnings
BioLineRx reports Q3 EPS (7c), consensus (9c) »

The company held $55M in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

SIG

Signet Jewelers

$75.84

-0.74 (-0.97%)

, ADS

Alliance Data

$224.67

0.32 (0.14%)

07:02
11/21/17
11/21
07:02
11/21/17
07:02
Hot Stocks
Signet in advanced talks with interested partners on more credit outsourcing »

On October 23, Signet…

SIG

Signet Jewelers

$75.84

-0.74 (-0.97%)

ADS

Alliance Data

$224.67

0.32 (0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 30

    Nov

  • 07

    Dec

  • 08

    Dec

  • 14

    Dec

ENSV

Enservco

$0.65

0.0196 (3.11%)

07:02
11/21/17
11/21
07:02
11/21/17
07:02
Hot Stocks
Enservco enters into agreement with bank »

Enservco announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DSW

DSW

$22.53

0.38 (1.72%)

07:02
11/21/17
11/21
07:02
11/21/17
07:02
Earnings
DSW sees FY17 adjusted EPS $1.40-$1.45, consensus $1.50 »

FY17 outlook reflects…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

DSW

DSW

$22.53

0.38 (1.72%)

07:00
11/21/17
11/21
07:00
11/21/17
07:00
Earnings
DSW reports Q3 adjusted EPS 45, consensus 53c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

SIG

Signet Jewelers

$75.84

-0.74 (-0.97%)

07:00
11/21/17
11/21
07:00
11/21/17
07:00
Earnings
Signet Jewelers lowers FY18 EPS view to $6.10-$6.50 from $7.16-$7.56 »

Consensus $7.02. Lowers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 07

    Dec

  • 08

    Dec

RXDX

Ignyta

$15.75

0.85 (5.70%)

07:00
11/21/17
11/21
07:00
11/21/17
07:00
Initiation
Ignyta initiated  »

Ignyta initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

LSI

Life Storage

$87.95

-0.73 (-0.82%)

07:00
11/21/17
11/21
07:00
11/21/17
07:00
Upgrade
Life Storage rating change  »

Life Storage upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SC

Santander Consumer

$17.07

0.75 (4.60%)

06:59
11/21/17
11/21
06:59
11/21/17
06:59
Recommendations
Santander Consumer analyst commentary  »

Santander Consumer added…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

06:59
11/21/17
11/21
06:59
11/21/17
06:59
Technical Analysis
S&P 500: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IRIX

IRIDEX

$7.63

-0.09 (-1.17%)

06:59
11/21/17
11/21
06:59
11/21/17
06:59
Conference/Events
IRIDEX management to meet with Roth Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 29

    Nov

SIG

Signet Jewelers

$75.84

-0.74 (-0.97%)

06:58
11/21/17
11/21
06:58
11/21/17
06:58
Earnings
Signet Jewelers now sees FY18 EPS $6.10-$6.50, consensus $7.02 »

Signet CEO Virginia…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 07

    Dec

  • 08

    Dec

GDX

Market Vector Gold Miners

$22.54

-0.25 (-1.10%)

06:58
11/21/17
11/21
06:58
11/21/17
06:58
Technical Analysis
Market Vector Gold Miners: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLD

SPDR Gold Trust

$121.31

-1.55 (-1.26%)

06:58
11/21/17
11/21
06:58
11/21/17
06:58
Technical Analysis
SPDR Gold Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUGT

Direxion Gold Miners Bull

$28.92

-0.88 (-2.95%)

06:57
11/21/17
11/21
06:57
11/21/17
06:57
Technical Analysis
Direxion Gold Miners Bull: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIG

Signet Jewelers

$75.84

-0.74 (-0.97%)

06:57
11/21/17
11/21
06:57
11/21/17
06:57
Earnings
Signet Jewelers reports Q3 EPS with items (20c), consensus 10c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 07

    Dec

  • 08

    Dec

JNUG

Direxion Daily Jr Gld Mnrs Bull 3X Shrs

$14.70

-0.82 (-5.28%)

06:57
11/21/17
11/21
06:57
11/21/17
06:57
Technical Analysis
Direxion Daily Jr Gld Mnrs Bull 3X Shrs: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HZN

Horizon Global

$14.38

0.49 (3.53%)

06:57
11/21/17
11/21
06:57
11/21/17
06:57
Conference/Events
Horizon Global management to meet with Roth Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

DUST

Direxion Daily Gold Miners Bear 3X ETF

$27.02

0.93 (3.56%)

06:56
11/21/17
11/21
06:56
11/21/17
06:56
Technical Analysis
Direxion Daily Gold Miners Bear 3X ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HK

Halcon Resources

$7.12

0.08 (1.14%)

06:56
11/21/17
11/21
06:56
11/21/17
06:56
Conference/Events
Halcon Resources management to meet with Imperial Capital »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 15

    May

JDST

Direxion Daily Junior Gold Miners Index Bear 3x Shares

$65.13

3.43 (5.56%)

06:56
11/21/17
11/21
06:56
11/21/17
06:56
Technical Analysis
Direxion Daily Junior Gold Miners Index Bear 3x Shares: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MBIN

Merchants Bancorp

$17.68

0.05 (0.28%)

06:55
11/21/17
11/21
06:55
11/21/17
06:55
Initiation
Merchants Bancorp initiated  »

Merchants Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MBIN

Merchants Bancorp

$17.68

0.05 (0.28%)

06:55
11/21/17
11/21
06:55
11/21/17
06:55
Initiation
Merchants Bancorp initiated  »

Merchants Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VXX

iPath S&P 500 VIX Short-Term Futures

$33.36

-1.09 (-3.16%)

06:55
11/21/17
11/21
06:55
11/21/17
06:55
Technical Analysis
iPath S&P 500 VIX Short-Term Futures: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.